Effect of butyrate analogues on proliferation and differentiation in human neuroblastoma cell lines

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1099-1103

  Rocchi, P ^a,b   Ferreri, A M ^a   Magrini, E ^a   Perocco, P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Istituto di Cancerologia   (Italy)

Author keywords

Butyrate analogues; Cell differentiation; Neuroblastoma

Indexed keywords

BUTYRAMIDE; BUTYRIC ACID DERIVATIVE; TRIBUTYRIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

AMIDES; CELL DIFFERENTIATION; CELL DIVISION; HUMANS; NEUROBLASTOMA; PHENOTYPE; TRIALKYLTIN COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0031812753     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Evans AE, Gerson J and Schnaufer L: Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44: 49-54,1976.
2. Evans AE, Chatten J, D'Angio GJ, Gerson JM, Robinson J and Schnaufer L: A review of 17 IV-S neuroblastoma patients at the Children's Hospital of Philadelphia.Cancer (Phila) 45: 833-838, 1980.
3. D'Angio GJ: Neuroblastoma overview-1986. Med Pediatr Oncol 15: 159-162, 1987.
4. Prasad KN: Butyric acid: a small fatty acid with diverse biological functions. Life Sci 27: 1351 -1358, 1980
5. Prasad KN and Sinha PK: Effect of sodium butyrate on mammalian cells in culture: a review. In vitro 12: 125-132, 1976.
6. Rocchi P, Ferrcri AM, Simone G, Granchi D, Paolucci P, Paolucci G: Growth inhibitory and differentiating effects of sodium butyrate on human neuroblastoma cells in culture. Anticancer Res 12: 917-920, 1972.
7. Leder A and Leder P: Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5: 319-322, 1975.
8. Boyd AW and Metcalf D: Induction of differentiation in HL60 leukaemic cells: a cell cycle dependent all-or-none event. Leuk Res 8: 27-43, 1984
9. Kruh J: Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42: 65-82, 1982.
10. Petit JM, Chauffert B, Dimanche-Boitrel MT, Genne P, Duchamp O and Martin F: mdrl gene-expression and villin synthesis in a colon cancer cell line differentiated by sodium butyrate. Anticancer Res 13: 487-490, 1993.
11. Augeron C and Laboisse CL: Emergence of permanently differentiated cell clones in a human colonie cell line in culture after treatment with sodium butyrate. Cancer Res 44: 3961-3969, 1984.
12. Miller AA, Kurschell E, Osieka R and Schmidt CG: Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23: 1283-1287, 1987.
13. Novogrodsky A, Dvir A, Ravid A, Shkolnik T, Stenzel KH, Rubin AL and Zaizov R: Effect of polar organic compounds on leukemic cells. Butyrate induced partial remission of acute myelogenous leukemia in a child. Cancer 51: 9-14, 1983.
14. Daniel P, Brazier M, Cerutti I, Pieri F, Tardivel I, Desmet G, Baillet J and Chany C: Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts. Clin Chem Acta 181: 255-264, 1989.
15. Pouillart P, Cerutti I, Ronco G, Villa P and Chany C: Enhancement by stable butyrate derivatives of antitumor and antiviral actions of interferon. Int J Cancer 51: 596-601, 1992.
16. Rephaeli A, Rabizadeh E, Aviram A,Shaklai M, Ruse M, Nudelman A: Derivatives of butyric acid as potential antineoplastic agent. Int J Cancer 49: 66-72, 1991.
17. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H and Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immunocomplexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229, 1984.
18. Liem RKH, Yen SH, Salomon GD and Shelanski ML: Intermediate filaments in nervous tissues. J Cell Biol 79: 637-645, 1978.
19. Drubin DG, Feinstein SC, Shooter EM and Kirschner MW: Nerve growth factor induced neurite outgrowth in PC 12 cells involves the coordinate induction of microtubule assembly promoting factors. J Cell Biol 101: 1799-1808, 1985.
20. Lazarides E: Intermediate filaments: a chemically heterogeneous developmentally regulated class of proteins. Annu Rev Biochem 51: 219-250,1982.
21. Chen ZX and Breitman TR: A prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res 54: 3494-3499,1994.
22. Lea MA, Xiao Q, Sadhukhan A, Sharma S and Newmark HL: Butyramide and monobutyrin: growth inhibithory and differentiating agents. Anticancer Res 13: 145-150,1993.
23. Lea MA and Tulsyan N: Discordant effects of butyrate analogues on erythroieukemia cell proliferation, differentiation and histone deacetylase. Anticancer Res 15: 879-884, 1995.
24. Planchon P, Raux H, Magnien V, Ronco G, Villa P, Crepin M and Brouty-Boye D: New stable butyrate derivatives alter proliferation and differentiation in human mammary cells. Int J Cancer 48: 443-449,1991.
25. Pouillart P, Cerutti I, Ronco G, Villa P and Chany C: Butyric monosaccharide ester-induced differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical application in cancer therapy. Int J Cancer 49: 98-95,1991.
26. Yuan Z, Eisernan J, Plaisance K, Sentz D, Bigora S, Fossler M, Young D and Egorin M: Plasma pharmacokinetics (PK) of butyrate after administration of tributyrin and Na butyrate to mice and rats. Proc Am Assoc Cancer Res 35: 429, 1994.